TUCSON, Ariz.--(BUSINESS WIRE)--Faxitron, a 50-year leader in advancing technology for breast health today announced that the U.S. Food and Drug Administration (FDA) has granted clearance to ...
TUCSON, Ariz.--(BUSINESS WIRE)--Faxitron, a global leader in best-in-class digital specimen imaging systems for breast cancer intervention and life science research, today announced that Carroll ...
Faxitron awarded exclusive distribution rights for Breast Lesion Localization System The LOCalizer AMSTERDAM, Jan. 26, 2017 /PRNewswire/ -- Faxitron® Bioptics, LLC and Health Beacons, Inc. today ...
Hologic, Inc. HOLX announced an extension of its LOCalizer radiofrequency identification (“RFID”) tag’s CE Mark. Under the extended approval, the tag can now be implanted more than 30 days prior to ...
accurately locates the Tag within millimeters. “The most exciting aspect of the LOCalizer technology is being able to accurately measure the distance to the target lesion, something we haven’t been ...
Hologic, Inc. HOLX announced an extension of its LOCalizer radiofrequency identification (“RFID”) tag’s CE Mark. Under the extended approval, the tag can now be implanted more than 30 days prior to ...
area of breast tissue during a procedure. The Tag can be implanted up to 30 days before surgery and is detected by a mobile, handheld Reader that accurately locates the Tag within millimeters. “The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback